4Midaelow 1C,Olsen K,Lozano J,et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children[J]. Pediatrics, 2004,113(4) :701-707.
5Nagalingam NA, Adesiyon AA, Swanaton WH, et al. Prevalence/of Mycoplasma pneumoniae and Chlamydia pneumoniae in pneumonia patients in four major hospital in Trinidad[J]. New Microbiol,2004,27(4):345-351.
6Rastawicki W, Kaluzewski S, Jagidski M, et al. Epidemiology of Mycoplasma pneumoniae in Poland:28 years of surveillance in Warsaw 1970-1997[J]. Euro Surveill, 1998,3(10) :99-100.
7Ngeow YF, Suwanjutha S, Chantarojinasriri T, et al. An Asian/study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia[J].Int J Infect Dis,2005,9(3) :144-153.
8Yu J, Yoo Y, Kim do K, et al. Distribution of antibody titers to Mycoplasma pneumoniae in Korean children in 2000-2003 [J]. J Korean Med Sci, 2005,20(4) :542-547.
9Korppi M, Heiskanen-Kosma T, Kleemola M. Incidence of community acquired pneumonia in children caused by Mycoplasma pneumoniae: serological results of a prospective,population-based study in primary health care[J]. Respirology, 2004,9(2) : 109-114.
10Csango PA, Pedersen JE,Hess RD.Comparison of four Mycoplasma pneumoniae IgM-, IgG-and IgA-spicificenzymee immunoassays in blood donors and patients [J]. Clin Microbiol Infect ,2004,10(12): 1094-1098.
